580. Clinical treatment pathways of antipsychotics in patients with schizophrenia spectrum disorder: a retrospective longitudinal observational study
Q Bo, T Li, Y Wang, Z Liu · 2026
Read 580. Clinical treatment pathways of antipsychotics in patients with schizophrenia spectrum disorder: a retrospective longitudinal observational study by Q Bo, T Li, Y Wang, Z Liu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13556588.txt.
Description
Bo and colleagues traced the order in which schizophrenia patients receive antipsychotic drugs in real hospital care. Trials say little about the paths patients actually follow after a first episode. Knowing those paths matters for spotting treatment resistance early. Late use of clozapine, the last-resort drug, is a known concern.
The team rebuilt drug histories for over three thousand patients at a psychiatric hospital. Five drugs made up nearly all first choices, led by quetiapine at about a third of starts. Switches mostly stayed inside the same five drugs. Among children, aripiprazole ranked first instead. Only twenty-seven patients started clozapine within a year of care. The authors argue that such pathway maps can guide more personal, timely care.
Catalog record
| CREATOR | Q Bo, T Li, Y Wang, Z Liu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |